Type II Glucocorticoid Receptors Are Involved in Neuronal Death and Astrocyte Activation Induced by Trimethyltin in the Rat Hippocampus

According to our previous study, trimethyltin (TMT), a neurotoxicant, induces the loss of pyramidal neurons in the rat hippocampus, which is preceded by a transient increase in plasma corticosterone concentration. To address whether this transient activation of the hypothalamopituitary–adrenocortica...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Experimental neurology 2001-09, Vol.171 (1), p.22-28
Hauptverfasser: Imai, Hideki, Nishimura, Tsutomu, Sadamatsu, Miyuki, Liu, Ying, Kabuto, Michinori, Kato, Nobumasa
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 28
container_issue 1
container_start_page 22
container_title Experimental neurology
container_volume 171
creator Imai, Hideki
Nishimura, Tsutomu
Sadamatsu, Miyuki
Liu, Ying
Kabuto, Michinori
Kato, Nobumasa
description According to our previous study, trimethyltin (TMT), a neurotoxicant, induces the loss of pyramidal neurons in the rat hippocampus, which is preceded by a transient increase in plasma corticosterone concentration. To address whether this transient activation of the hypothalamopituitary–adrenocortical axis is related to neuronal loss in the hippocampus, we evaluated the effects of bilateral adrenalectomy (ADX) and the chronic supplemental treatment of glucocorticoid receptor agonists after ADX on TMT-induced hippocampal damage. Peroral administration of a single dose of TMT (9 mg/kg body wt) induced the extensive loss of CA3 pyramidal neurons and reactive astrocytosis in the hippocampus, as evidenced by results of vimentin and glial fibrillary acidic protein immunohistochemistry, and the effects were profoundly exacerbated by bilateral adrenalectomy. Prolonged administration of corticosterone not only attenuated the exacerbating effects of adrenalectomy but also partially reversed the TMT-induced neuronal loss and reactive astrocytosis. Dexamethasone, but not aldosterone, could be substituted for corticosterone, suggesting a novel neuroprotective action of type II glucocorticoid receptors in the hippocampus.
doi_str_mv 10.1006/exnr.2001.7725
format Article
fullrecord <record><control><sourceid>elsevier_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1006_exnr_2001_7725</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0014488601977258</els_id><sourcerecordid>S0014488601977258</sourcerecordid><originalsourceid>FETCH-LOGICAL-c436t-d7fdefbe94c3f8148d64ceef68f10c2f9a680a0c08e213cb244665dea95324573</originalsourceid><addsrcrecordid>eNp1kEFr2zAUgMXYWLNu1x2HLjs6e5JlWz6GbmsDpYOSnY3y9Ew0HMtIcph_Qf_2FBLoaSAQSN8nnj7GPgtYC4D6G_0dw1oCiHXTyOoNWwlooZCqhLdslY9VobSub9iHGP8AQKtk857dCFFJEEKv2MtumYhvt_x-mNGjD8mhd5Y_E9KUfIh8E_L9ePLDiSx3I3-iOfjRDPw7mXTgZrR8E1PwuCTiG0zuZJLzY3bsjFnZL3wX3JHSYRlS9vNKB-LPJvEHN00ezXGa40f2rjdDpE_X_Zb9_vljd_dQPP66395tHgtUZZ0K2_SW-j21CsteC6VtrZCor3UvAGXfmlqDAQRNUpS4l0rVdWXJtFUpVdWUt2x9eReDjzFQ3015OBOWTkB3Ltqdi3bnot25aBa-XIRp3h_JvuLXhBn4egVMRDP0wYzo4iunoNINtJnTF47y906OQhfR0ZgTuUCYOuvd_2b4BwMXlHI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Type II Glucocorticoid Receptors Are Involved in Neuronal Death and Astrocyte Activation Induced by Trimethyltin in the Rat Hippocampus</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Imai, Hideki ; Nishimura, Tsutomu ; Sadamatsu, Miyuki ; Liu, Ying ; Kabuto, Michinori ; Kato, Nobumasa</creator><creatorcontrib>Imai, Hideki ; Nishimura, Tsutomu ; Sadamatsu, Miyuki ; Liu, Ying ; Kabuto, Michinori ; Kato, Nobumasa</creatorcontrib><description>According to our previous study, trimethyltin (TMT), a neurotoxicant, induces the loss of pyramidal neurons in the rat hippocampus, which is preceded by a transient increase in plasma corticosterone concentration. To address whether this transient activation of the hypothalamopituitary–adrenocortical axis is related to neuronal loss in the hippocampus, we evaluated the effects of bilateral adrenalectomy (ADX) and the chronic supplemental treatment of glucocorticoid receptor agonists after ADX on TMT-induced hippocampal damage. Peroral administration of a single dose of TMT (9 mg/kg body wt) induced the extensive loss of CA3 pyramidal neurons and reactive astrocytosis in the hippocampus, as evidenced by results of vimentin and glial fibrillary acidic protein immunohistochemistry, and the effects were profoundly exacerbated by bilateral adrenalectomy. Prolonged administration of corticosterone not only attenuated the exacerbating effects of adrenalectomy but also partially reversed the TMT-induced neuronal loss and reactive astrocytosis. Dexamethasone, but not aldosterone, could be substituted for corticosterone, suggesting a novel neuroprotective action of type II glucocorticoid receptors in the hippocampus.</description><identifier>ISSN: 0014-4886</identifier><identifier>EISSN: 1090-2430</identifier><identifier>DOI: 10.1006/exnr.2001.7725</identifier><identifier>PMID: 11520118</identifier><identifier>CODEN: EXNEAC</identifier><language>eng</language><publisher>Amsterdam: Elsevier Inc</publisher><subject>Adrenalectomy ; aldosterone ; Aldosterone - pharmacology ; Animals ; Astrocytes - cytology ; Astrocytes - drug effects ; Astrocytes - metabolism ; Biological and medical sciences ; Blood. Blood coagulation. Reticuloendothelial system ; Cell Count ; Cell Death - drug effects ; dexamethasone ; Dexamethasone - pharmacology ; Glial Fibrillary Acidic Protein - biosynthesis ; Gliosis - chemically induced ; Gliosis - pathology ; Glucocorticoids - pharmacology ; hippocampus ; Hippocampus - cytology ; Hippocampus - drug effects ; Hippocampus - metabolism ; Hypothalamo-Hypophyseal System - metabolism ; Immunohistochemistry ; Male ; Medical sciences ; Neurons - cytology ; Neurons - drug effects ; Neurons - metabolism ; Pharmacology. Drug treatments ; Pituitary-Adrenal System - metabolism ; Pyramidal Cells - cytology ; Pyramidal Cells - drug effects ; Pyramidal Cells - metabolism ; Rats ; Rats, Sprague-Dawley ; Receptors, Glucocorticoid - agonists ; Receptors, Glucocorticoid - metabolism ; trimethyltin ; Trimethyltin Compounds - pharmacology ; vimentin ; Vimentin - biosynthesis</subject><ispartof>Experimental neurology, 2001-09, Vol.171 (1), p.22-28</ispartof><rights>2001 Academic Press</rights><rights>2002 INIST-CNRS</rights><rights>Copyright 2001 Academic Press.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c436t-d7fdefbe94c3f8148d64ceef68f10c2f9a680a0c08e213cb244665dea95324573</citedby><cites>FETCH-LOGICAL-c436t-d7fdefbe94c3f8148d64ceef68f10c2f9a680a0c08e213cb244665dea95324573</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1006/exnr.2001.7725$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=14058709$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11520118$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Imai, Hideki</creatorcontrib><creatorcontrib>Nishimura, Tsutomu</creatorcontrib><creatorcontrib>Sadamatsu, Miyuki</creatorcontrib><creatorcontrib>Liu, Ying</creatorcontrib><creatorcontrib>Kabuto, Michinori</creatorcontrib><creatorcontrib>Kato, Nobumasa</creatorcontrib><title>Type II Glucocorticoid Receptors Are Involved in Neuronal Death and Astrocyte Activation Induced by Trimethyltin in the Rat Hippocampus</title><title>Experimental neurology</title><addtitle>Exp Neurol</addtitle><description>According to our previous study, trimethyltin (TMT), a neurotoxicant, induces the loss of pyramidal neurons in the rat hippocampus, which is preceded by a transient increase in plasma corticosterone concentration. To address whether this transient activation of the hypothalamopituitary–adrenocortical axis is related to neuronal loss in the hippocampus, we evaluated the effects of bilateral adrenalectomy (ADX) and the chronic supplemental treatment of glucocorticoid receptor agonists after ADX on TMT-induced hippocampal damage. Peroral administration of a single dose of TMT (9 mg/kg body wt) induced the extensive loss of CA3 pyramidal neurons and reactive astrocytosis in the hippocampus, as evidenced by results of vimentin and glial fibrillary acidic protein immunohistochemistry, and the effects were profoundly exacerbated by bilateral adrenalectomy. Prolonged administration of corticosterone not only attenuated the exacerbating effects of adrenalectomy but also partially reversed the TMT-induced neuronal loss and reactive astrocytosis. Dexamethasone, but not aldosterone, could be substituted for corticosterone, suggesting a novel neuroprotective action of type II glucocorticoid receptors in the hippocampus.</description><subject>Adrenalectomy</subject><subject>aldosterone</subject><subject>Aldosterone - pharmacology</subject><subject>Animals</subject><subject>Astrocytes - cytology</subject><subject>Astrocytes - drug effects</subject><subject>Astrocytes - metabolism</subject><subject>Biological and medical sciences</subject><subject>Blood. Blood coagulation. Reticuloendothelial system</subject><subject>Cell Count</subject><subject>Cell Death - drug effects</subject><subject>dexamethasone</subject><subject>Dexamethasone - pharmacology</subject><subject>Glial Fibrillary Acidic Protein - biosynthesis</subject><subject>Gliosis - chemically induced</subject><subject>Gliosis - pathology</subject><subject>Glucocorticoids - pharmacology</subject><subject>hippocampus</subject><subject>Hippocampus - cytology</subject><subject>Hippocampus - drug effects</subject><subject>Hippocampus - metabolism</subject><subject>Hypothalamo-Hypophyseal System - metabolism</subject><subject>Immunohistochemistry</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Neurons - cytology</subject><subject>Neurons - drug effects</subject><subject>Neurons - metabolism</subject><subject>Pharmacology. Drug treatments</subject><subject>Pituitary-Adrenal System - metabolism</subject><subject>Pyramidal Cells - cytology</subject><subject>Pyramidal Cells - drug effects</subject><subject>Pyramidal Cells - metabolism</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Receptors, Glucocorticoid - agonists</subject><subject>Receptors, Glucocorticoid - metabolism</subject><subject>trimethyltin</subject><subject>Trimethyltin Compounds - pharmacology</subject><subject>vimentin</subject><subject>Vimentin - biosynthesis</subject><issn>0014-4886</issn><issn>1090-2430</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kEFr2zAUgMXYWLNu1x2HLjs6e5JlWz6GbmsDpYOSnY3y9Ew0HMtIcph_Qf_2FBLoaSAQSN8nnj7GPgtYC4D6G_0dw1oCiHXTyOoNWwlooZCqhLdslY9VobSub9iHGP8AQKtk857dCFFJEEKv2MtumYhvt_x-mNGjD8mhd5Y_E9KUfIh8E_L9ePLDiSx3I3-iOfjRDPw7mXTgZrR8E1PwuCTiG0zuZJLzY3bsjFnZL3wX3JHSYRlS9vNKB-LPJvEHN00ezXGa40f2rjdDpE_X_Zb9_vljd_dQPP66395tHgtUZZ0K2_SW-j21CsteC6VtrZCor3UvAGXfmlqDAQRNUpS4l0rVdWXJtFUpVdWUt2x9eReDjzFQ3015OBOWTkB3Ltqdi3bnot25aBa-XIRp3h_JvuLXhBn4egVMRDP0wYzo4iunoNINtJnTF47y906OQhfR0ZgTuUCYOuvd_2b4BwMXlHI</recordid><startdate>20010901</startdate><enddate>20010901</enddate><creator>Imai, Hideki</creator><creator>Nishimura, Tsutomu</creator><creator>Sadamatsu, Miyuki</creator><creator>Liu, Ying</creator><creator>Kabuto, Michinori</creator><creator>Kato, Nobumasa</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20010901</creationdate><title>Type II Glucocorticoid Receptors Are Involved in Neuronal Death and Astrocyte Activation Induced by Trimethyltin in the Rat Hippocampus</title><author>Imai, Hideki ; Nishimura, Tsutomu ; Sadamatsu, Miyuki ; Liu, Ying ; Kabuto, Michinori ; Kato, Nobumasa</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c436t-d7fdefbe94c3f8148d64ceef68f10c2f9a680a0c08e213cb244665dea95324573</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Adrenalectomy</topic><topic>aldosterone</topic><topic>Aldosterone - pharmacology</topic><topic>Animals</topic><topic>Astrocytes - cytology</topic><topic>Astrocytes - drug effects</topic><topic>Astrocytes - metabolism</topic><topic>Biological and medical sciences</topic><topic>Blood. Blood coagulation. Reticuloendothelial system</topic><topic>Cell Count</topic><topic>Cell Death - drug effects</topic><topic>dexamethasone</topic><topic>Dexamethasone - pharmacology</topic><topic>Glial Fibrillary Acidic Protein - biosynthesis</topic><topic>Gliosis - chemically induced</topic><topic>Gliosis - pathology</topic><topic>Glucocorticoids - pharmacology</topic><topic>hippocampus</topic><topic>Hippocampus - cytology</topic><topic>Hippocampus - drug effects</topic><topic>Hippocampus - metabolism</topic><topic>Hypothalamo-Hypophyseal System - metabolism</topic><topic>Immunohistochemistry</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Neurons - cytology</topic><topic>Neurons - drug effects</topic><topic>Neurons - metabolism</topic><topic>Pharmacology. Drug treatments</topic><topic>Pituitary-Adrenal System - metabolism</topic><topic>Pyramidal Cells - cytology</topic><topic>Pyramidal Cells - drug effects</topic><topic>Pyramidal Cells - metabolism</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Receptors, Glucocorticoid - agonists</topic><topic>Receptors, Glucocorticoid - metabolism</topic><topic>trimethyltin</topic><topic>Trimethyltin Compounds - pharmacology</topic><topic>vimentin</topic><topic>Vimentin - biosynthesis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Imai, Hideki</creatorcontrib><creatorcontrib>Nishimura, Tsutomu</creatorcontrib><creatorcontrib>Sadamatsu, Miyuki</creatorcontrib><creatorcontrib>Liu, Ying</creatorcontrib><creatorcontrib>Kabuto, Michinori</creatorcontrib><creatorcontrib>Kato, Nobumasa</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Experimental neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Imai, Hideki</au><au>Nishimura, Tsutomu</au><au>Sadamatsu, Miyuki</au><au>Liu, Ying</au><au>Kabuto, Michinori</au><au>Kato, Nobumasa</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Type II Glucocorticoid Receptors Are Involved in Neuronal Death and Astrocyte Activation Induced by Trimethyltin in the Rat Hippocampus</atitle><jtitle>Experimental neurology</jtitle><addtitle>Exp Neurol</addtitle><date>2001-09-01</date><risdate>2001</risdate><volume>171</volume><issue>1</issue><spage>22</spage><epage>28</epage><pages>22-28</pages><issn>0014-4886</issn><eissn>1090-2430</eissn><coden>EXNEAC</coden><abstract>According to our previous study, trimethyltin (TMT), a neurotoxicant, induces the loss of pyramidal neurons in the rat hippocampus, which is preceded by a transient increase in plasma corticosterone concentration. To address whether this transient activation of the hypothalamopituitary–adrenocortical axis is related to neuronal loss in the hippocampus, we evaluated the effects of bilateral adrenalectomy (ADX) and the chronic supplemental treatment of glucocorticoid receptor agonists after ADX on TMT-induced hippocampal damage. Peroral administration of a single dose of TMT (9 mg/kg body wt) induced the extensive loss of CA3 pyramidal neurons and reactive astrocytosis in the hippocampus, as evidenced by results of vimentin and glial fibrillary acidic protein immunohistochemistry, and the effects were profoundly exacerbated by bilateral adrenalectomy. Prolonged administration of corticosterone not only attenuated the exacerbating effects of adrenalectomy but also partially reversed the TMT-induced neuronal loss and reactive astrocytosis. Dexamethasone, but not aldosterone, could be substituted for corticosterone, suggesting a novel neuroprotective action of type II glucocorticoid receptors in the hippocampus.</abstract><cop>Amsterdam</cop><pub>Elsevier Inc</pub><pmid>11520118</pmid><doi>10.1006/exnr.2001.7725</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0014-4886
ispartof Experimental neurology, 2001-09, Vol.171 (1), p.22-28
issn 0014-4886
1090-2430
language eng
recordid cdi_crossref_primary_10_1006_exnr_2001_7725
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Adrenalectomy
aldosterone
Aldosterone - pharmacology
Animals
Astrocytes - cytology
Astrocytes - drug effects
Astrocytes - metabolism
Biological and medical sciences
Blood. Blood coagulation. Reticuloendothelial system
Cell Count
Cell Death - drug effects
dexamethasone
Dexamethasone - pharmacology
Glial Fibrillary Acidic Protein - biosynthesis
Gliosis - chemically induced
Gliosis - pathology
Glucocorticoids - pharmacology
hippocampus
Hippocampus - cytology
Hippocampus - drug effects
Hippocampus - metabolism
Hypothalamo-Hypophyseal System - metabolism
Immunohistochemistry
Male
Medical sciences
Neurons - cytology
Neurons - drug effects
Neurons - metabolism
Pharmacology. Drug treatments
Pituitary-Adrenal System - metabolism
Pyramidal Cells - cytology
Pyramidal Cells - drug effects
Pyramidal Cells - metabolism
Rats
Rats, Sprague-Dawley
Receptors, Glucocorticoid - agonists
Receptors, Glucocorticoid - metabolism
trimethyltin
Trimethyltin Compounds - pharmacology
vimentin
Vimentin - biosynthesis
title Type II Glucocorticoid Receptors Are Involved in Neuronal Death and Astrocyte Activation Induced by Trimethyltin in the Rat Hippocampus
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T09%3A33%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Type%20II%20Glucocorticoid%20Receptors%20Are%20Involved%20in%20Neuronal%20Death%20and%20Astrocyte%20Activation%20Induced%20by%20Trimethyltin%20in%20the%20Rat%20Hippocampus&rft.jtitle=Experimental%20neurology&rft.au=Imai,%20Hideki&rft.date=2001-09-01&rft.volume=171&rft.issue=1&rft.spage=22&rft.epage=28&rft.pages=22-28&rft.issn=0014-4886&rft.eissn=1090-2430&rft.coden=EXNEAC&rft_id=info:doi/10.1006/exnr.2001.7725&rft_dat=%3Celsevier_cross%3ES0014488601977258%3C/elsevier_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/11520118&rft_els_id=S0014488601977258&rfr_iscdi=true